Retroviridae Proteins, Oncogenic
"Retroviridae Proteins, Oncogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.
| Descriptor ID |
D015682
|
| MeSH Number(s) |
D12.776.624.664.520.750 D12.776.964.700.750 D12.776.964.775.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Retroviridae Proteins, Oncogenic".
Below are MeSH descriptors whose meaning is more specific than "Retroviridae Proteins, Oncogenic".
This graph shows the total number of publications written about "Retroviridae Proteins, Oncogenic" by people in this website by year, and whether "Retroviridae Proteins, Oncogenic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Retroviridae Proteins, Oncogenic" by people in Profiles.
-
Nerurkar VR, Song KJ, Bastian IB, Garin B, Franchini G, Yanagihara R. Genotyping of human T cell lymphotropic virus type I using Australo-Melanesian topotype-specific oligonucleotide primer-based polymerase chain reaction: insights into viral evolution and dissemination. J Infect Dis. 1994 Dec; 170(6):1353-60.
-
Rao VN, Reddy ES. elk-1 proteins interact with MAP kinases. Oncogene. 1994 Jul; 9(7):1855-60.
-
Sherman MP, Dube S, Spicer TP, Kane TD, Love JL, Saksena NK, Iannone R, Gibbs CJ, Yanagihara R, Dube DK, et al. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia. Cancer Res. 1993 Dec 15; 53(24):6067-73.
-
Hoshino H, Nakamura T, Tanaka Y, Miyoshi I, Yanagihara R. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I. J Infect Dis. 1993 Dec; 168(6):1368-73.
-
Bhattacharya G, Lee L, Reddy ES, Rao VN. Transcriptional activation domains of elk-1, delta elk-1 and SAP-1 proteins. Oncogene. 1993 Dec; 8(12):3459-64.
-
Nerurkar VR, Babu PG, Song KJ, Melland RR, Gnanamuthu C, Saraswathi NK, Chandy M, Godec MS, John TJ, Yanagihara R. Sequence analysis of human T cell lymphotropic virus type I strains from southern India: gene amplification and direct sequencing from whole blood blotted onto filter paper. J Gen Virol. 1993 Dec; 74 ( Pt 12):2799-805.
-
Rao VN, Reddy ES. Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase. Cancer Res. 1993 Aug 01; 53(15):3449-54.
-
Siddique HR, Rao VN, Lee L, Reddy ES. Characterization of the DNA binding and transcriptional activation domains of the erg protein. Oncogene. 1993 Jul; 8(7):1751-5.
-
Rao VN, Reddy ES. Delta elk-1, a variant of elk-1, fails to interact with the serum response factor and binds to DNA with modulated specificity. Cancer Res. 1993 Jan 15; 53(2):215-20.
-
Rao VN, Reddy ES. elk-1 domains responsible for autonomous DNA binding, SRE:SRF interaction and negative regulation of DNA binding. Oncogene. 1992 Nov; 7(11):2335-40.